Neurologix, Inc. NRGXQ Company Overview  Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Neurologix, Inc. NRGXQ Company Overview 

Stock Message Board http://investorshangout.com/search?q=NRGXQ&am...mp;yt1=Go!

Neurologix, Inc. NRGXQ Current Price and Quotes
Last Price 0.0016
Previous Close 0.0016 Open N/A
Daily Range N/A - N/A 52wk Range 0.005 - 0.001
Volume 0 Dividend N/A
Average Vol (3m) 66,011 Yield N/A
Neurologix, Inc. NRGXQ
Company Information

One Bridge Plaza
Fort Lee, NJ 07024

Website: http://www.neurologix.net
Phone: 201-592-6451
Email: info@neurologix.net

Neurologix, Inc. NRGXQ
Neurologix, Inc. (NRGX.OB) is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of life-altering gene transfer therapies for serious disorders of the brain and Central Nervous System (CNS).

Neurologix, Inc. NRGXQ
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2011 10-Q
CIK 0000356591
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Adrian Adams CEO
Reginald L. Hardy Vice President
Andrew Koven President, Chief Admin. Officer
Company Directors

Adrian Adams Chairman
Reginald L. Hardy
Clark A. Johnson
Andrew Koven
Company Notes

Note=2-04 company is in the development stage, developing proprietary gene therapies for treating central nervous system disorders
Formerly=Change Technology Partners, Inc. until 2-04
Note=9-00 State of Incorporation New Mexico changed to Delaware concurrent with name change
Formerly=Arinco Computer Systems, Inc until 9-00
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Neurologix, Inc. NRGXQ
NRGXQ Security Details

Share Structure

Market Value1 $44,796 a/o Sep 13, 2013
Shares Outstanding 27,997,701 a/o May 01, 2011
Float Not Available
Authorized Shares Not Available
Par Value  0.01
Shareholders

Shareholders of Record 268 a/o Mar 25, 2011
Security Notes

New Issue=10-82 1,000,000 shs in units (1 sh Com & 1 Warr 4-14-84) at 50 cents per unit (best efforts-750,000 min.) by Anthony Investment Co. et al.
Capital Change=shs decreased by 1 for 25 split. Pay date=09/10/2004.
Short Selling Data

Short Interest 0 (-100%)
May 31, 2012
Significant Failures to Deliver  No
Transfer Agent(s)

Computershare Trust Company Inc.

Neurologix, Inc. NRGXQ Recent News

Neurologix, Inc. NRGXQ Financials
NRGXQ


NRGXQ Neurologix, Inc. Research DD Guide

NRGXQ Neurologix, Inc. Stock Message Board http://investorshangout.com/search?q=NRGXQ&am...mp;yt0=Go!
NRGXQ Neurologix, Inc. Stock Quote http://www.otcmarkets.com/stock/NRGXQ/quote
NRGXQ Neurologix, Inc. Stock Chart http://www.otcmarkets.com/stock/NRGXQ/chart
NRGXQ Neurologix, Inc. Company Info http://www.otcmarkets.com/stock/NRGXQ/company-info
NRGXQ Neurologix, Inc. Recent News http://www.otcmarkets.com/stock/NRGXQ/news
NRGXQ Neurologix, Inc. Financials http://www.otcmarkets.com/stock/NRGXQ/financials
NRGXQ Neurologix, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/NRGXQ/filings
NRGXQ Neurologix, Inc. Short Sales http://www.otcmarkets.com/stock/NRGXQ/short-sales
NRGXQ Neurologix, Inc. Insider Disclosure http://www.otcmarkets.com/stock/NRGXQ/insider-transactions
NRGXQ Neurologix, Inc. Research Reports http://www.otcmarkets.com/stock/NRGXQ/research
NRGXQ Neurologix, Inc. Summary http://finance.yahoo.com/q?s=NRGXQ
NRGXQ Neurologix, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=NRGXQ+Historical+Prices
NRGXQ Neurologix, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=NRGXQ
NRGXQ Neurologix, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=NRGXQ+Basic+Chart
NRGXQ Neurologix, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=NRGXQ+Basic+Tech.+Analysis
NRGXQ Neurologix, Inc. Headlines http://finance.yahoo.com/q/h?s=NRGXQ+Headlines
NRGXQ Neurologix, Inc. Press Releases http://finance.yahoo.com/q/p?s=NRGXQ+Press+Releases
NRGXQ Neurologix, Inc. Company Profile http://finance.yahoo.com/q/pr?s=NRGXQ+Profile
NRGXQ Neurologix, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=NRGXQ+Key+Statistics
NRGXQ Neurologix, Inc. Industry http://finance.yahoo.com/q/in?s=NRGXQ+Industry
NRGXQ Neurologix, Inc. Major Holders http://finance.yahoo.com/q/mh?s=NRGXQ+Major+Holders
NRGXQ Neurologix, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=NRGXQ+Insider+Transactions
NRGXQ Neurologix, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=NRGXQ+Insider+Roster
NRGXQ Neurologix, Inc. Income Statement http://finance.yahoo.com/q/is?s=NRGXQ
NRGXQ Neurologix, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=NRGXQ
NRGXQ Neurologix, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=NRGXQ+Cash+Flow&annual
NRGXQ Neurologix, Inc. Nasdaq http://www.nasdaq.com/symbol/NRGXQ
NRGXQ Neurologix, Inc. Market Watch http://www.marketwatch.com/investing/stock/NRGXQ
NRGXQ Neurologix, Inc. Bloomberg http://www.bloomberg.com/quote/NRGXQ:US
NRGXQ Neurologix, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=NRGXQ
NRGXQ Neurologix, Inc. Bussinessweek http://investing.businessweek.com/research/st...cker=NRGXQ
NRGXQ Neurologix, Inc. Barchart http://www.barchart.com/quotes/stocks/NRGXQ
NRGXQ Neurologix, Inc. OTC Short Report http://otcshortreport.com/index.php?index=NRGXQ
NRGXQ Neurologix, Inc. Investopedia http://www.investopedia.com/markets/stocks/NRGXQ/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 1

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 34

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Dickinson Brands Celebrates Witch Hazel Legacy with Event

Updated Category News Views 0

Witch Hazel's Timeless Appeal You don’t get to celebrate over one and a half centuries of a product without doing something right. Dickinson Brands Inc. is throwing a bash worth noticing as they mark the sixth annual National Witch Hazel Day on October 21st. It’s a head-nod to the versatile witch hazel, a product that’s been part of New England's heritage since the...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 1

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Angels on Call Sets Benchmark for Specialized Homecare

Updated Category News Views 2

Pioneering a New Standard in Homecare Take a gander at Angels on Call Homecare. They're not just another name in a crowded field; they've carved out a niche—specializing in elite care for Dementia and Parkinson's patients. You don't usually hear homecare and innovation in the same breath, do you? But these folks are setting a fresh benchmark. Independent feedback has...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 41

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

Updated Category News Views 1

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

Continue Reading
New Chapter Recovery Garners Key Accreditations

Updated Category News Views 0

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

Continue Reading
AI-Designed Antivirals: A Brave New World

Updated Category News Views 2

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights into FGI Industries' Upcoming Earnings Report

Updated Category News Views 143

FGI Industries Earnings Report Overview FGI Industries (NASDAQ: FGI) is preparing to reveal its quarterly earnings, creating anticipation among investors. Although the report was initially set for a future date, the expectation remains high for significant news regarding the company's performance and guidance. Expected Earnings and Analyst Insights Analysts project that...

Continue Reading
US SMEs Shift Focus Towards High-Quality and Trendy Products

Updated Category News Views 211

Changing Priorities for US SMEs in Product Sourcing Small and medium-sized enterprises (SMEs) in the United States are gearing up for significant shifts in how they source products in the coming year. A striking 44% of these businesses are on the lookout for new suppliers, prioritizing cost efficiency and product quality above all else. This transformation is highlighted...

Continue Reading
TD Bank Resolves AML Issues, Boosts Analyst Confidence

Updated Category News Views 87

TD Bank's Outlook After Resolving AML Issues Scotiabank has reaffirmed its Sector Outperform rating for Toronto-Dominion Bank (TD:CN) (NYSE: TD), setting its price target at Cdn$86.00. This positive assessment comes after the resolution of TD's anti-money laundering (AML) challenges in the United States, which had raised uncertainties following the failed acquisition of...

Continue Reading
Centene Corporation Urges Shareholders to Reject TRC Offer

Updated Category News Views 139

Centene Corporation Advises Shareholders Centene Corporation (NYSE: CNC) has recently communicated important news regarding an unsolicited offer from TRC Capital Investment Corporation. TRC has proposed a 'mini-tender' offer to purchase up to 4 million shares of Centene's common stock at a price of $24.75 per share. This offer, however, is lower than the current market...

Continue Reading
Liberty Defense's New Offering: What It Means for Investors

Updated Category News Views 289

Liberty Defense Holdings Announces an Exciting New Offering Liberty Defense Holdings Ltd. (NASDAQ: LDDFF) is making waves with its announcement regarding an overnight marketed offering of units. This offering aims to finance their innovative journey in creating AI-based detection solutions for concealed weapons and potential threats in various sectors. As a key player in...

Continue Reading